Revenue | ₹1.11Cr |
Net Profits | ₹0.28Cr |
Net Profit Margins | -25.23% |
Norris Medicines Ltd’s revenue jumped 70.77% since last year same period to ₹1.11Cr in the Q3 2024-2025. On a quarterly growth basis, Norris Medicines Ltd has generated -12.6% fall in its revenue since last 3-months.
Norris Medicines Ltd’s net profit fell -3.7% since last year same period to ₹0.28Cr in the Q3 2024-2025. On a quarterly growth basis, Norris Medicines Ltd has generated 22.22% jump in its net profits since last 3-months.
Norris Medicines Ltd’s net profit margin jumped 39.27% since last year same period to -25.23% in the Q3 2024-2025. On a quarterly growth basis, Norris Medicines Ltd has generated 11.01% jump in its net profit margins since last 3-months.
The revenue for Norris Medicines Ltd in the Q3 results 2024 was ₹1.11Cr.
The net profit for Norris Medicines Ltd in the Q3 results 2024 was ₹0.28Cr.
The net profit margin for Norris Medicines Ltd in the Q3 results 2024 was -25.23%.
The revenue for Norris Medicines Ltd in the Q3 results 2023 was ₹0.65Cr.
The net profit for Norris Medicines Ltd in the Q3 results 2023 was ₹0.27Cr.
The net profit margin for Norris Medicines Ltd in the Q3 results 2023 was -41.54%.